Reduced levels of phospho-Drp1 (Ser616) in PINK1-/- tumor cells shown here, and impaired PINK1/Parkin-mediated proteasomal degradation of mitofusin (36, 56–58), may have contributed to increased mitochondrial fusion in PINK1-/- tumor cells. The gene discussed is PRKN; the disease is neoplasm.